Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Milind Javle

Showing results (61-70 of 226) with videos related to

Pageof 23
Sort By:
Transplantation|March 29, 2020
Liver Transplantation for Cholangiocarcinoma and Mixed Hepatocellular Cholangiocarcinoma: Working Group Report From the ILTS Transplant Oncology Consensus ConferenceGonzalo Sapisochin, Milind Javle, Jan Lerut, et al.
Investigational New Drugs|May 8, 2020
Phase I study of DFP-11207, a novel oral fluoropyrimidine with reasonable AUC and low C<sub>max</sub> and improved tolerability, in patients with solid tumorsJaffer A Ajani, Milind Javle, Cathy Eng, et al.
American Journal of Clinical Oncology|October 11, 2008
Pilot study of gefitinib, oxaliplatin, and radiotherapy for esophageal adenocarcinoma: tissue effect predicts clinical responseMilind Javle, Amitkumar Pande, Renuka Iyer, et al.
International Journal of Gastrointestinal Cancer|August 20, 2005
Expression of intestinal trefoil factor (TFF-3) in hepatocellular carcinomaThaer Khoury, Krishdeep Chadha, Milind Javle, et al.
Cancer Treatment Reviews|March 24, 2020
Broadening the therapeutic horizon of advanced biliary tract cancer through molecular characterisationAvani Athauda, Caroline Fong, David K Lau, et al.
Biochimica Et Biophysica Acta|March 17, 2016
The inflammatory inception of gallbladder cancerJaime A Espinoza, Carolina Bizama, Patricia García, et al.
Molecular Cancer Therapeutics|April 15, 2018
Clinical Next-Generation Sequencing for Precision Oncology in Rare CancersRoman Groisberg, David S Hong, Jason Roszik, et al.
Anticancer Research|April 22, 2011
Evidence for the efficacy of Iniparib, a PARP-1 inhibitor, in BRCA2-associated pancreatic cancerDavid R Fogelman, Robert A Wolff, Scott Kopetz, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 28, 2025
CLO25-099: Lenvatinib With Pembrolizumab in Advanced Biliary Tract CancerKabir Grewal, Shubham Pant, Ian Hu, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|May 4, 2004
Epidermal growth factor receptor expression correlates with histologic grade in resected esophageal adenocarcinomaNeal W Wilkinson, Jennifer D Black, Elena Roukhadze, et al.
Pageof 23

Showing results (61-70 of 226) with videos related to

Sort By:
Pageof 23
Transplantation|March 29, 2020
Liver Transplantation for Cholangiocarcinoma and Mixed Hepatocellular Cholangiocarcinoma: Working Group Report From the ILTS Transplant Oncology Consensus ConferenceGonzalo Sapisochin, Milind Javle, Jan Lerut, et al.
Investigational New Drugs|May 8, 2020
Phase I study of DFP-11207, a novel oral fluoropyrimidine with reasonable AUC and low C<sub>max</sub> and improved tolerability, in patients with solid tumorsJaffer A Ajani, Milind Javle, Cathy Eng, et al.
American Journal of Clinical Oncology|October 11, 2008
Pilot study of gefitinib, oxaliplatin, and radiotherapy for esophageal adenocarcinoma: tissue effect predicts clinical responseMilind Javle, Amitkumar Pande, Renuka Iyer, et al.
International Journal of Gastrointestinal Cancer|August 20, 2005
Expression of intestinal trefoil factor (TFF-3) in hepatocellular carcinomaThaer Khoury, Krishdeep Chadha, Milind Javle, et al.
Cancer Treatment Reviews|March 24, 2020
Broadening the therapeutic horizon of advanced biliary tract cancer through molecular characterisationAvani Athauda, Caroline Fong, David K Lau, et al.
Biochimica Et Biophysica Acta|March 17, 2016
The inflammatory inception of gallbladder cancerJaime A Espinoza, Carolina Bizama, Patricia García, et al.
Molecular Cancer Therapeutics|April 15, 2018
Clinical Next-Generation Sequencing for Precision Oncology in Rare CancersRoman Groisberg, David S Hong, Jason Roszik, et al.
Anticancer Research|April 22, 2011
Evidence for the efficacy of Iniparib, a PARP-1 inhibitor, in BRCA2-associated pancreatic cancerDavid R Fogelman, Robert A Wolff, Scott Kopetz, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 28, 2025
CLO25-099: Lenvatinib With Pembrolizumab in Advanced Biliary Tract CancerKabir Grewal, Shubham Pant, Ian Hu, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|May 4, 2004
Epidermal growth factor receptor expression correlates with histologic grade in resected esophageal adenocarcinomaNeal W Wilkinson, Jennifer D Black, Elena Roukhadze, et al.
Pageof 23